MeD Rx

Pharmaceutical Analysis for Insurance and Industry
Medical Data Mining Services

With the advent of Rx information in life and health risk management, coupled with the information and investigative aspect of teleunderwriting, insurance companies are starting to appreciate a new gold standard in risk assessment. This is because so many helpful inferences can be made from the Rx—whether prescribed or over the counter; whether conventional or from the vast domain of alternative and complementary medicine—that a proposed insured is taking. This is especially true when the Rx information gathered on the teleinterview is interfaced with all of the other information on the specific impairment drilldowns.

A friend once said, “Tell me what he’s taking and I’ll tell you what he’s got.” The problem is just that simple—how to make the most informed decisions. The equation required to solve this problem would look something like this:

Rx = Dx = Tx, with Dx meaning the probable diagnosis and Tx meaning the decision that’s made with the proper information. RSA Medical feels we have the common denominator…MedRx.